Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
TISSUE BANKING Challenging to Say the Least
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility.
Subcommittee on Harmonization Mark Barnes David Forster.
ORD Human Research Protection K. Lynn Cates, MD Assistant Chief Research & Development Officer February 25, 2004.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Introduction to Regulation
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
NIH’s Efforts to Promote the Harmonization of Clinical Research Policies Secretary’s Advisory Committee on Human Research Protections October 27, 2009.
NIH Proposed Use of a Central IRB (C-IRB) for NIH-funded multi-site studies Committee on Clinical Research January 26,
October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD
William B Munier, MD, MBA, Director Center for Quality Improvement and Patient Safety Agency for Healthcare Research and Quality AHRQ Annual Conference.
Research Bioethics Consultation: More potential than sequencing genomes Benjamin S. Wilfond MD Seattle Children’s Hospital Treuman Katz Center for Pediatric.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
Overview of Good Clinical Practices (GCPs)
Internal Auditing and Outsourcing
Central IRBs: Ceding IRB Oversight
Accreditation of Research Programs: How it Might Affect your Research Harvey Murff, M.D., M.P.H. Director of Research Safety GCRC, Vanderbilt University.
The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
A. Short term problems / considerations b. Long term mission View of human subjects protection system: SACHRP July 2008 Elizabeth Bankert.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
Sara Brand Associate Director Research Compliance Administration.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
Secretary’s Advisory Committee on Human Subjects Protections (SACHRP) Summary of Responses on: Advanced Notice of Proposed Rulemaking (ANPRM) on Holding.
Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.
Common Rule and FDA Regulation Comparison David Forster Jeff Cooper Gary Chadwick.
East Tennessee State University. Full Accreditation Association for the Accreditation of Human Research Protection Programs (AAHRPP)
1 Investigating Fraud & Abuse Violations in Medical Research Janet Rehnquist, Esq. Venable LLP th Street, NW Washington, DC
Questions: AAHRPP Evaluation Instrument for Use with Final Revised Accreditation Standards Presented by: C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst,
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Status of SACHRP Recommendations July 2003-October 2008 Meeting of the Secretary’s Advisory Committee on Human Research Protections October 27, 2008 Michael.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
1 Human Subject Protection: Thoughts from OHRP Bernard A. Schwetz, D.V.M., Ph.D. Director, Office for Human Research Protections Department of Health and.
OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
The Wisconsin Network for Health Research (WiNHR): Overview. An Infrastructure for Conducting Multi-Site Clinical Research across the State of Wisconsin.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator Local Accountability Meeting June 2011.
Office of Research Oversight VHA Handbook VHA OPERATIONS ACTIVITIES THAT MAY CONSTITUTE RESEARCH Establishes standards and procedures for determining.
SACHRP PANEL: HOLDING EXTERNAL IRBS ACCOUNTABLE David L. Wynes, Ph.D. Vice President for Research Administration Emory University July 21, 2009.
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
 Section 808(d) of the Fair Housing Act, as amended, provides:  All executive departments and agencies shall administer their programs and activities.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
VA Central IRB MOU Webinar K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Adverse events reporting system at Kaiser Permanente: Promoting collaboration for the protection of human subjects Arthur Durazo IRB Administrator Kaiser.
Bussara Sukpanichnant, Human Subject Protection Office, USAMD-AFRIMS Unanticipated Problems 15 th FERCAP International Conference 24 Nov 15 Nagasaki, Japan.
Working Group on IT Security and Privacy in VA and NIH Sponsored Research Joel Kupersmith, MD Chief Research & Development Officer.
NIH Clinical Trial Requirements
National Immunization Conference April 19, 2010
Informed Consent (SBER)
Changes to the Common Rule and Single IRB (sIRB)
Presentation transcript:

Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of Veterans Affairs October 17, 2005

SACHRP Secretary’s Advisory Committee on Human Research Protection, HHS* Purpose To provide expert advice & recommendations to the Secretary of HHS & the Assistant Secretary for Health on issues and topics pertaining to or associated with the protection of human research subjects. *Authority: 42 U.S.C. 217a, section 222, PHS Act

Emerging SACHRP Issues Federal Adverse Events Taskforce (FAET) IRB Workshop

Federal Adverse Event Taskforce Charge Propose specific means for promoting harmonized and streamlined federal requirements for reporting, analyzing, and communicating adverse events in clinical research.

Federal Adverse Event Taskforce Member Agencies AHRQ CDC DoD FDA OHRP NIH VA

Federal Adverse Events Taskforce Objectives 1.Common terms & definitions 2.Common AE report forms 3.Common workflow patterns 4.Communications

1. Common Terms & Definitions Reduce variability in language e.g., “unanticipated problem” vs. “adverse event” or “unanticipated” vs. “unexpected” Align federal agencies’ policies & guidance

2. Common AE Report Forms Basal Adverse Event Report (BAER) Develop a baseline set of core information adopted by all agencies Address individual agency needs by adding extra fields

3. Common Workflow Patterns Develop a best practices blue print for reporting, analyzing, and applying AE data

AE Reporting in Multi-Center Clinical Trials: Trans-Federal Guidance Clarify regulatory requirements for reporting and reviewing adverse events from multi-center trials Outline criteria for when AE reports should be forwarded to other sites Work with industry and academia

4. Communication Effective communication Enhance subjects’ safety Further scientific knowledge Earn public trust

FAET Focus Groups Examine current practices at the local level What safety information does an IRB receive and when? How is the safety information analyzed? How and to whom is it communicated? Identify Problem Areas Does government contribute? Define what needs to be done

VA Local Management of Adverse Events: Mission Ensure that local management of unanticipated problems in research, including adverse events, assures maximal protection for VA research participants, and complies fully with all laws, regulations, and standards.

VA Local Management of Adverse Events: Charge Identifying/Reporting What should be reported? When should it be reported? Where should it be reported? Monitoring Who monitors? What is monitored? What trends/patterns require further action?

VA Local Management of Adverse Events: Charge Research v. Patient Safety Corrective Action Who takes action? What are appropriate actions? When does it become research misconduct?

Alternatives to Current IRBs IRB Workshop VA Central IRB “What is Research?” Panel

IRB Workshop Steering Group OHRP NIH AAMC ASCO VA November 17-18, 2005, Washington, DC

IRB Workshop Invitational, exploratory meeting Diverse perspectives IRBs Academic and community-based investigators Attorneys Patients Ethicists Industry officials Senior university and medical school research administrators

IRB Workshop Topics Institutional responsibilities Ways to reduce burdens (especially for multi-site trials) Costs and other barriers The federal policy framework relevant to new IRB arrangements

IRB Workshop: Follow-on Activities Report for SACHRP on The suitability of alternative models of IRB review for different research contexts Strategies to address barriers Public meeting

VA Central IRB Review multi-site VA studies Assure quality by ensuring appropriate representation (scientific, ethical, “community”) Enhance efficiency

VA Central IRB: Timeline Fall 2005 Implementation strategies Policies & procedures Begin recruitment process for IRB Administrator Site visits to NCI CIRB, Western & Chesapeake Winter IRB Chair and field input Summer & Fall 2006 Training – local accountability

Alternatives to Current IRB System “What is Research?” Panel Responsibilities Review multi-site projects to determine whether or not they are “research” Develop guidance for the field on “What is Research?” (vs. Quality) High level representatives from ORD, ORO, Ethics, Patient Services, Quality